AIM Vaccine Co., Ltd. (6660.HK)

HKD 3.39

(-0.29%)

Net Income Summary of AIM Vaccine Co., Ltd.

  • AIM Vaccine Co., Ltd.'s latest annual net income in 2023 was -1.3 Billion CNY , down -307.07% from previous year.
  • AIM Vaccine Co., Ltd.'s latest quarterly net income in 2024 Q2 was -139.25 Million CNY , up 86.75% from previous quarter.
  • AIM Vaccine Co., Ltd. reported an annual net income of -319.6 Million CNY in 2022, up 53.87% from previous year.
  • AIM Vaccine Co., Ltd. reported an annual net income of -692.77 Million CNY in 2021, down -282.65% from previous year.
  • AIM Vaccine Co., Ltd. reported a quarterly net income of -250.36 Million CNY for 2023 Q2, up 8.87% from previous quarter.
  • AIM Vaccine Co., Ltd. reported a quarterly net income of -1.05 Billion CNY for 2023 Q4, down -319.64% from previous quarter.

Annual Net Income Chart of AIM Vaccine Co., Ltd. (2023 - 2019)

Historical Annual Net Income of AIM Vaccine Co., Ltd. (2023 - 2019)

Year Net Income Net Income Growth
2023 -1.3 Billion CNY -307.07%
2022 -319.6 Million CNY 53.87%
2021 -692.77 Million CNY -282.65%
2020 379.28 Million CNY 223.06%
2019 117.4 Million CNY 0.0%

Peer Net Income Comparison of AIM Vaccine Co., Ltd.

Name Net Income Net Income Difference
Uni-Bio Science Group Limited 70.87 Million HKD 1935.607%
CK Life Sciences Int'l., (Holdings) Inc. 17.25 Million HKD 7642.058%